Showing results (191-200 of 735) with videos related to

Sort By:
Pageof 74
Clinical Lymphoma, Myeloma & Leukemia|March 28, 2025
Real-World Data on Outcome of Burkitt Lymphoma and Burkitt Leukemia Treated According to the GMALL B-ALL/NHL 2002 Protocol: A Tertiary Center ExperienceRicardo Kosch, Christoph Schaefers, Christian Frenzel, et al.
European Urology|June 3, 2011
EAU guidelines on testicular cancer: 2011 updatePeter Albers, Walter Albrecht, Ferran Algaba, et al.
The Oncologist|October 27, 2005
Management of cancer-related anemia in patients with breast or gynecologic cancer: new insights based on results from the European Cancer Anemia SurveyPeter Barrett-Lee, Carsten Bokemeyer, Pere Gascón, et al.
Future Oncology (London, England)|March 5, 2019
Chemotherapy-induced neutropenia/febrile neutropenia prophylaxis with biosimilar filgrastim in solid tumors versus hematological malignancies: MONITOR-GCSF studyHeinz Ludwig, Carsten Bokemeyer, Matti Aapro, et al.
Hamostaseologie|February 9, 2024
Multisite Thrombosis in a Patient with Paroxysmal Nocturnal HemoglobinuriaLennart Beckmann, Tobias D Faizy, Fabian Flottmann, et al.
Leukemia & Lymphoma|August 8, 2023
The prognostic impact of lymphoma perforation in patients with primary gastrointestinal lymphoma - a single-center analysisFranziska Modemann, Paymon Ahmadi, Philipp H von Kroge, et al.
Diagnostic Pathology|July 26, 2015
Cdc7 overexpression is an independent prognostic marker and a potential therapeutic target in colorectal cancerNathaniel Melling, Johanna Muth, Ronald Simon, et al.
European Urology|June 28, 2011
Long-term survival after treatment with gemcitabine and oxaliplatin with and without paclitaxel plus secondary surgery in patients with cisplatin-refractory and/or multiply relapsed germ cell tumorsKarin Oechsle, Christian Kollmannsberger, Friedemann Honecker, et al.
The Journal of Pathology|June 29, 2004
Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cellsFriedemann Honecker, Hans Stoop, Ronald R de Krijger, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 27, 2015
Treatment patterns and outcomes in the prophylaxis of chemotherapy-induced (febrile) neutropenia with biosimilar filgrastim (the MONITOR-GCSF study)Pere Gascón, Matti Aapro, Heinz Ludwig, et al.
Pageof 74